| Product Code: ETC9562452 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Industry Life Cycle |
3.4 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Porter's Five Forces |
3.5 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Growing focus on precision medicine and patient-centric healthcare |
4.2.3 Advancements in pharmacogenomics technology leading to improved diagnostic accuracy |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenomics testing and companion diagnostics |
4.3.2 Limited reimbursement policies for personalized medicine in healthcare systems |
4.3.3 Regulatory challenges and complexities in implementing theranostics |
5 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Trends |
6 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Types |
6.1 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.4 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By In-situ Hybridization, 2021- 2031F |
6.1.5 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.1.7 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.4 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.5 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunological Disorders, 2021- 2031F |
6.2.6 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Export to Major Countries |
7.2 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Imports from Major Countries |
8 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenomics technology in clinical settings |
8.2 Number of partnerships between pharmaceutical companies and diagnostic companies for companion diagnostics development |
8.3 Rate of integration of theranostics into routine clinical practice in Sweden |
9 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Opportunity Assessment |
9.1 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Competitive Landscape |
10.1 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Pharmacogenomics Technology Theranostics Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here